Robert Matthew Fesinmeyer

Title: The Innovations of Robert Matthew Fesinmeyer

Introduction

Robert Matthew Fesinmeyer is an accomplished inventor based in Newbury Park, CA (US). He has made significant contributions to the field of protein formulations, holding a total of 2 patents. His work focuses on enhancing the efficacy and usability of antibody formulations.

Latest Patents

Fesinmeyer's latest patents include "Excipients to reduce the viscosity of antibody formulations" and "VEGFR-Fc fusion protein formulations." The first patent addresses a series of excipients capable of effectively reducing the viscosity of protein formulations. These viscosity-reducing excipients are oligopeptides, such as dipeptides and tripeptides, which include at least one arginine. The peptides may also incorporate basic, acidic, hydrophilic, or hydrophobic/aromatic amino acids. An arginine residue can be positioned at either the amino or carboxyl end of the oligopeptide. The second patent provides formulations and methods for creating and utilizing protein formulations, which can be ophthalmic, such as for intravitreal administration. This formulation may include a VEGFR-Fc fusion protein, like aflibercept.

Career Highlights

Fesinmeyer is currently associated with Amgen Inc., a leading biotechnology company. His work at Amgen has allowed him to focus on innovative solutions in the field of biopharmaceuticals.

Collaborations

Throughout his career, Fesinmeyer has collaborated with notable colleagues, including Jian Hua Gu and Rulin Qian. These collaborations have contributed to the advancement of his research and the development of his patented technologies.

Conclusion

Robert Matthew Fesinmeyer is a prominent inventor whose work in protein formulations has led to significant advancements in the field. His innovative patents reflect his commitment to improving biopharmaceutical applications.